Profile: Vernalis PLC (VER.L)

VER.L on London Stock Exchange

59.75GBp
5 May 2015
Change (% chg)

-- (--)
Prev Close
59.75p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,730,918
52-wk High
62.55p
52-wk Low
28.58p

Search Stocks
Vernalis plc is a United Kingdom-based research and development-stage pharmaceutical company. Vernalis has one marketed product and a portfolio of development and drug discovery programmes. Vernalis has nine active collaborations, four covering programmes in pre-clinical through to Phase II development and four active drug discovery collaborations. Its commercial pipeline includes CCP-01, CCP-05, CCP-06, CCP-07 and CCP-08. The Company operates in the United Kingdom, Rest of Europe, North America and Rest of the World.

Company Address

Vernalis PLC

100 Berkshire Place/Wharfedale R
WINNERSH     RG41 5RD
P: +44118.9380000
F: +44118.9380001

Company Web Links

Search Stocks